Age-related macular degeneration (AMD) is the leading cause of blindness in the West. Delays in injections can cause ...

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus, a Sight-Threatening Rare DiseaseALISO VIEJO, ...

Women over 50 face increased eye health risks post-menopause due to hormonal shifts. Conditions like dry eye, cataracts, ...

Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the ...

World Optometry Day aims to celebrate optometry’s contribution to global health and its ongoing efforts to improve access to ...

OCGN's gene-agnostic eye therapy aims to treat multiple retinal mutations, with key filings and pivotal data in 2026???2027 set to test its broad platform.

As China enters the peak spring pollen season, hospitals are reporting a sharp rise in allergy cases, with growing demand for ...

Chugai Pharma files regulatory application with Japanese MHLW for medical device component of the Port Delivery Platform with ranibizumab: Tokyo Friday, March 20, 2026, 11:00 Hrs ...

Harrow, Inc. is rapidly evolving into a dominant US ophthalmic pharma player, with a 30-fold revenue increase since 2015 and ...

Positive initial data reported from Phase 1a Single Ascending Dose study in nAMD in December 2025; preliminary data from ongoing Phase 1b/2 study expected in 1H 2027 Intend to initiate Phase 3 ...

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, ...

Doctors struggle with mounting cases as Israeli controls prevent entry of medicines and equipment ...